| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Hospital & Healthcare Services
|
Compare with Industry peers |
| Website | http://www.fortismalar.com | |
| Market Cap | 160.56 Cr. | |
| Enterprise Value(EV) | 130.79 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -8.38 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 67.33 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 29.51 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 2.90 | Calculated using Price: 85.67 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.87 Cr. | 18,741,759 Shares |
| FaceValue | 10 | |
| About Fortis Malar Hospitals Ltd. | ||
| Malar Hospitals (an Associate of Fortis Healthcare), like every other Fortis hospital, is a manifestation of the founder's vision of creating a world-class integrated healthcare delivery system in India, entailing the finest medical skills combined with compassionate patient care. | ||
| 1 Day |
|
-1.99% |
| 1 Week |
|
+3.77% |
| 1 Month |
|
+53.78% |
| 3 Month |
|
+50.40% |
| 6 Month |
|
+13.02% |
| 1 Year |
|
+75.95% |
| 2 Year |
|
+47.33% |
| 5 Year |
|
+52.57% |
| 10 Year |
|
+218.48% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 8.93 | 6.8 | 3.16 | 3.28 | 1.97 | -8.82 | -8.5 | -9.8 | -21.46 | |
| Return on Capital Employed (%) | 14.17 | 10.96 | 5 | 5.9 | 3.17 | -4.09 | -4.44 | -2.02 | -1.3 | |
| Return on Assets (%) | 6.85 | 4.97 | 2.4 | 2.4 | 1.39 | -5.27 | -4.51 | -5.29 | -10.66 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 91 | 98 | 100 | 103 | 105 | 96 | 89 | 80 | 64 | 59 | |
| Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 56 | 47 | 41 | 42 | 38 | |
| Curr. Liab. | 37 | 32 | 30 | 45 | 44 | 36 | 25 | 31 | 32 | 31 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 128 | 130 | 130 | 148 | 149 | 188 | 161 | 152 | 138 | 129 | |
| Non Curr. Assets | 20 | 28 | 33 | 34 | 37 | 126 | 101 | 103 | 54 | 52 | |
| Curr. Assets | 108 | 102 | 97 | 113 | 112 | 62 | 60 | 49 | 84 | 77 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 128 | 130 | 130 | 148 | 149 | 188 | 161 | 152 | 138 | 129 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 118 | 130 | 141 | 149 | 145 | 112 | 69 | 86 | 86 | 74 | |
| Other Income | 8 | 9 | 8 | 8 | 10 | 11 | 8 | 7 | 7 | 7 | |
| Total Income | 126 | 138 | 149 | 158 | 155 | 123 | 78 | 94 | 93 | 81 | |
| Total Expenditure | -110 | -124 | -140 | -147 | -147 | -115 | -76 | -83 | -81 | -75 | |
| PBIDT | 15 | 14 | 9 | 10 | 8 | 8 | 2 | 11 | 11 | 6 | |
| Interest | -1 | 0 | 0 | 0 | -1 | -8 | -7 | -7 | -6 | -5 | |
| Depreciation | -3 | -3 | -4 | -4 | -4 | -13 | -13 | -13 | -12 | -12 | |
| Taxation | -4 | -4 | -1 | -2 | -1 | 3 | 3 | 0 | -8 | -5 | |
| Exceptional Items | -1 | 7 | |||||||||
| PAT | 8 | 6 | 3 | 3 | 2 | -9 | -8 | -8 | -15 | -16 | |
| Minority Interest | |||||||||||
| Share Associate | |||||||||||
| Other Related Items | |||||||||||
| Consolidated Net Profit | 8 | 6 | 3 | 3 | 2 | -9 | -8 | -8 | -15 | -16 | |
| Adjusted EPS | 4 | 3 | 2 | 2 | 1 | -5 | -4 | -4 | -8 | -8 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 5 | 4 | 10 | -9 | 9 | -16 | 0 | -1 | 7 | 6 | |
| Cash Fr. Inv. | -1 | 5 | -22 | 13 | -2 | 6 | 50 | -28 | 8 | 1 | |
| Cash Fr. Finan. | -1 | -1 | -1 | 0 | 0 | -12 | -7 | -10 | -13 | ||
| Net Change | 3 | 10 | -13 | 4 | 7 | -9 | 38 | -36 | 5 | -7 | |
| Cash & Cash Eqvt | 6 | 16 | 3 | 7 | 15 | 5 | 43 | 7 | 12 | 6 |
|
Wed, 01 May 2024
Announcement under Regulation 30 (LODR)-Change in Management The Company has appointed Mr. Ramesh L. Adige as Non Executive Non-Independent Director of the Company with effect from May 6 2024 the detailed disclosure is enclosed. |
|
Wed, 01 May 2024
Announcement under Regulation 30 (LODR)-Change in Directorate The Company has appointed Mr. Ramesh L. Adige as Non Executive Non Independent Director of the Company with effect from May 6 2024 the detailed disclosure is enclosed. |
|
Mon, 22 Apr 2024
PCS Certificate Under Regulation 40(10) Of SEBI Listing Regulations 2015 Please find the enclosed PCS Certificate as per Regulation 40(10) of SEBI LODR Regulations 2015 |
| Fri, 03 May 2024 |
Opening at High
|
Opening at Low
|
Opening at High for 3 days
|
Closing Below Previous Low
|
Opening at High for 2 Days
|
